Fierce Medtech

Ardent Health taps Fujifilm’s AI-enabled patient imaging platform fiercebiotech.com/medtech/ardent…

Boston Scientific funnels $1.5B into MiRus, with option to buy TAVR system fiercebiotech.com/medtech/boston…

Despite prolonged policy uncertainty in the U.S., many healthcare and life sciences execs are still seeing opportunities amid the tumult. On “The Top Line,” Fierce Pharma's Fraiser Kansteiner talks with @PwC's U.S. health industries leader about tariffs, drug pricing reform, AI and the future of U.S. healthcare innovation. fiercepharma.com/pharma/health-…

“Outliers are what you're going for,” Model Medicines CEO Daniel Haders told Fierce to explain the company's AI-driven drug development strategy. fiercebiotech.com/biotech/how-mo…

New Hepta blood test could predict GLP-1 response fiercebiotech.com/medtech/new-he…

From shrinking drug development timelines to scouting potential acquisitions, the recent run of first-quarter earnings results marked a shift for Big Pharma from AI hype to explaining how the technology is being applied in practice. fiercebiotech.com/biotech/drug-d…

Insulet boosts guidance in Q1 update as it grapples with recall saga fiercebiotech.com/medtech/insule…

J&J is touting positive results from the first study of its soft-tissue surgical robot, showing the system can safely perform gastric bypass surgery. fiercebiotech.com/medtech/jjs-ot… $JNJ

Foundation Medicine links with Fulgent Genetics to offer new gene test fiercebiotech.com/medtech/founda…

Sanofi expands AI capabilities, investing $294M to scale Toronto hub fiercepharma.com/pharma/sanofi-… $SNY

Olympus, EndoRobotics in distribution pact for robot-assisted endoscopic tech fiercebiotech.com/medtech/olympu…

Genomics inks partnership deal with Greywolf to assess gene datasets fiercebiotech.com/medtech/genomi…

Labcorp raises full-year guidance, boosted by diagnostics, lab services fiercebiotech.com/medtech/labcor… $LH

FDA unveils plan for real-time review of clinical trial data, with AstraZeneca and Amgen already on board fiercebiotech.com/biotech/fda-un…

GE HealthCare is cutting its profit outlook while making structural changes to its business and executive teams. fiercebiotech.com/medtech/rising…

Merck KGaA, Remepy team up on software-enhanced hybrid drugs for rare tumors fiercebiotech.com/medtech/merck-…

Medtronic said it contained a cyberattack on its corporate IT systems and that the breach didn’t impact any of its products or patients. fiercebiotech.com/medtech/medtro…

Blood test powered by AI shows early promise in monitoring rare childhood cancer fiercebiotech.com/medtech/blood-…

Thermo Fisher Scientific is shedding its microbiology business to a private equity firm nearly a year after rumors of a potential sale first surfaced. fiercebiotech.com/medtech/thermo…

Johnson & Johnson is working with the AI-based disease detection and care coordination platform Viz.ai to boost its neurovascular offerings. fiercebiotech.com/medtech/johnso…